Search Results - Roshni Ravindranathan
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer by Lily Francis, Zong Sheng Guo, Zuqiang Liu, Roshni Ravindranathan, Julie Urban, Magesh Sathaiah, Deepa Magge, Paweł Kaliński, David L. Bartlett
Published 2016Artigo -
5
Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade by Stacy J. Kowalsky, Zuqiang Liu, Mathilde Feist, Sara E. Berkey, Congrong Ma, Roshni Ravindranathan, Enyong Dai, Edward J. Roy, Zong Sheng Guo, David L. Bartlett
Published 2018Artigo -
6
Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers by Stephanie Downs‐Canner, Zong Sheng Guo, Roshni Ravindranathan, Caroline J. Breitbach, Mark E. O’Malley, Heather Jones, Anne Moon, J. Andrea McCart, Yongli Shuai, Herbert J. Zeh, David L. Bartlett
Published 2016Artigo -
7
Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy by Mathilde Feist, Zhi Zhu, Enyong Dai, Congrong Ma, Zuqiang Liu, Esther Giehl, Roshni Ravindranathan, Stacy J. Kowalsky, Nataša Obermajer, Udai S. Kammula, Andrew J. H. Lee, Michael T. Lotze, Zong Sheng Guo, David L. Bartlett
Published 2020Artigo
Search Tools:
Related Subjects
Immunology
Oncolytic virus
Immune system
Medicine
Cancer
Cancer research
Immunotherapy
Internal medicine
Biology
CD8
Biochemistry
Gene
Recombinant DNA
Tumor microenvironment
Vaccinia
Cancer cell
Cancer immunotherapy
Chemokine
Cytotoxic T cell
Immunity
In vitro
Ovarian cancer
Virotherapy
Virus
Acquired immune system
Adoptive cell transfer
Adverse effect
Antigen
Astrobiology
Blockade